Cargando…
Pharmacogenomics in epilepsy
There is high variability in the response to antiepileptic treatment across people with epilepsy. Genetic factors significantly contribute to such variability. Recent advances in the genetics and neurobiology of the epilepsies are establishing the basis for a new era in the treatment of epilepsy, fo...
Autores principales: | Balestrini, Simona, Sisodiya, Sanjay M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Scientific Publishers Ireland
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846849/ https://www.ncbi.nlm.nih.gov/pubmed/28082152 http://dx.doi.org/10.1016/j.neulet.2017.01.014 |
Ejemplares similares
-
Rare and Complex Epilepsies from Childhood to Adulthood: Requirements for Separate Management or Scope for a Lifespan Holistic Approach?
por: Balestrini, Simona, et al.
Publicado: (2021) -
Risk factors and outcome of hyperammonaemia in people with epilepsy
por: Vakrinou, Angeliki, et al.
Publicado: (2022) -
Transcranial magnetic stimulation as a tool to understand genetic conditions associated with epilepsy
por: Silvennoinen, Katri, et al.
Publicado: (2020) -
Steps to Improve Precision Medicine in Epilepsy
por: Balestrini, S., et al.
Publicado: (2023) -
Cortical myoclonus and epilepsy in a family with a new SLC20A2 mutation
por: Coppola, Antonietta, et al.
Publicado: (2020)